Back
United Therapeutics Corp. Stock Price Chart
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis Now
Sell
45
UTHR
United Therapeutics Corp.
Last Price:
$467.32
Seasonality Move:
-2.82%
7 Day Trial
ALL ACCESS PASS
$
7
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing selling pressure, which indicates risk of future bearish movement.
United Therapeutics Corp. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 470.15 | Sell |
| 20-day SMA: | 480.92 | Sell |
| 50-day SMA: | 486.26 | Sell |
| 200-day SMA: | 380.65 | Buy |
| 8-day EMA: | 103.84 | Buy |
| 20-day EMA: | 44.5 | Buy |
| 50-day EMA: | 18.33 | Buy |
| 200-day EMA: | 4.65 | Buy |
United Therapeutics Corp. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 37.28 | Buy |
| Relative Strength Index (14 RSI): | 40.24 | Sell |
| Chaikin Money Flow: | -189338 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
United Therapeutics Corp. Technical Analysis
| Jan 14 | Jan 15 | Jan 16 | Jan 20 | Jan 21 | Jan 22 | Jan 23 | Jan 26 | Jan 27 | Jan 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 14 | 15 | 16 | 20 | 21 | 22 | 23 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for United Therapeutics Corp. Stock
Is United Therapeutics Corp. Stock a Buy?
-
United Therapeutics Corp. share price is 467.30 while UTHR 8-day simple moving average is 470.15, which is a Sell signal.
-
The stock price of UTHR is 467.30 while United Therapeutics Corp. 20-day SMA is 480.92, which makes it a Sell.
-
United Therapeutics Corp. 50-day simple moving average is 486.26 while UTHR share price is 467.30, making it a Sell technically.
-
UTHR stock price is 467.30 and United Therapeutics Corp. 200-day simple moving average is 380.65, creating a Buy signal.
UTHR Technical Analysis vs Fundamental Analysis
Sell
45
United Therapeutics Corp. (UTHR)
is a Sell
Is United Therapeutics Corp. a Buy or a Sell?
-
United Therapeutics Corp. stock is rated a SellThe current United Therapeutics Corp. [UTHR] share price is $467.30. The Score for UTHR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
United Therapeutics Corp. Stock Info
Market Cap:
20.1B
Price in USD:
467.30
Share Volume:
274.2K
United Therapeutics Corp. 52-Week Range
52-Week High:
519.99
52-Week Low:
266.98
Sell
45
United Therapeutics Corp. (UTHR)
is a Sell
United Therapeutics Corp. Share Price Forecast
-
What is the United Therapeutics Corp. stock price today?The United Therapeutics Corp. stock price is 467.30 USD today.
-
Will UTHR stock go up or go down?United Therapeutics Corp.> share price is forecast to RISE/FALL based on technical indicators
-
Is United Therapeutics Corp. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, United Therapeutics Corp. is overvalued.
Is United Therapeutics Corp. Stock a Buy?
-
United Therapeutics Corp. share price is 467.30 while UTHR 8-day exponential moving average is 103.84, which is a Buy signal.
-
The stock price of UTHR is 467.30 while United Therapeutics Corp. 20-day EMA is 44.50, which makes it a Buy.
-
United Therapeutics Corp. 50-day exponential moving average is 18.33 while UTHR share price is 467.30, making it a Buy technically.
-
UTHR stock price is 467.30 and United Therapeutics Corp. 200-day simple moving average is 4.65, creating a Buy signal.
Fundamental Analysis of United Therapeutics Corp.
Is United Therapeutics Corp. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.81 per share, and an increase next year of $1.56 per share.
Technical Analysis of United Therapeutics Corp.
Should I short United Therapeutics Corp. stock?
-
UTHR Moving Average Covergence Divergence (MACD) indicator is 37.28, suggesting United Therapeutics Corp. is a Buy
-
United Therapeutics Corp. Relative Strength Index (RSI) is 40.24, which suggest United Therapeutics Corp. is oversold
-
The Bollinger Bands (25) for United Therapeutics Corp. is ( - ), which suggest United Therapeutics Corp. is a Buy
-
The Bollinger Bands (100) for United Therapeutics Corp. is ( - ), which suggest United Therapeutics Corp. is a Buy
* United Therapeutics Corp. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.